STRATA Skin Sciences, Inc., a medical technology company, focuses on the therapeutic and aesthetic dermatology market. The company operates through three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment, and Dermatology Imaging. Its products include XTRAC laser and VTRAC excimer lamp systems used for the treatment of psoriasis, vitiligo, and other skin conditions; the STRATAPEN MicroSystems, a micropigmentation device; and Nordlys, a multi-technology aesthetic laser device for treating vascular and pigmented lesions. STRATA Skin Sciences, Inc. was founded in 1989 and is based in Horsham, Pennsylvania.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Phone215-619-3200
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$31.45 million
Profitability
Miscellaneous
Employees98
OptionableNot Optionable
STRATA Skin Sciences (NASDAQ:SSKN) Frequently Asked Questions
What is STRATA Skin Sciences' stock symbol?
STRATA Skin Sciences trades on the NASDAQ under the ticker symbol "SSKN."
When did STRATA Skin Sciences' stock split? How did STRATA Skin Sciences' stock split work?
STRATA Skin Sciences's stock reverse split on Thursday, July 10th 2014. The 1-10 reverse split was announced on Thursday, July 3rd 2014. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 9th 2014. An investor that had 100 shares of STRATA Skin Sciences stock prior to the reverse split would have 10 shares after the split.
How were STRATA Skin Sciences' earnings last quarter?
STRATA Skin Sciences Inc (NASDAQ:SSKN) posted its earnings results on Monday, April, 20th. The medical device company reported ($1.14) EPS for the quarter, missing analysts' consensus estimates of ($0.37) by $0.77. STRATA Skin Sciences had a negative return on equity of 18.83% and a negative net margin of 18.33%. View STRATA Skin Sciences' Earnings History.
When is STRATA Skin Sciences' next earnings date?
What price target have analysts set for SSKN?
3 equities research analysts have issued 12 month price objectives for STRATA Skin Sciences' shares. Their forecasts range from $5.00 to $7.00. On average, they anticipate STRATA Skin Sciences' share price to reach $6.00 in the next year. This suggests a possible upside of 86.9% from the stock's current price. View Analyst Price Targets for STRATA Skin Sciences.
What is the consensus analysts' recommendation for STRATA Skin Sciences?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STRATA Skin Sciences in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for STRATA Skin Sciences.
What are Wall Street analysts saying about STRATA Skin Sciences stock?
Here are some recent quotes from research analysts about STRATA Skin Sciences stock:
- 1. According to Zacks Investment Research, "Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. " (11/16/2018)
- 2. HC Wainwright analysts commented, "Valuation and risks to price target achievement. We maintain our Buy rating with a price target of $5. Our price target is based on our clinical net present value (NPV) model, which is currently driven by the company’s lead asset, XTRAC, and project upside from: (1) increase in patients treated for lead indication psoriasis; and (2) increasing traction for XTRAC in its other approved indications, vitiligo and eczema/ atopic dermatitis." (10/10/2018)
Has STRATA Skin Sciences been receiving favorable news coverage?
News stories about SSKN stock have trended positive recently, according to InfoTrie Sentiment. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. STRATA Skin Sciences earned a daily sentiment score of 2.3 on InfoTrie's scale. They also gave headlines about the medical device company a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an impact on the stock's share price in the next few days.
Who are some of STRATA Skin Sciences' key competitors?
Some companies that are related to STRATA Skin Sciences include Pulse Biosciences (PLSE), GenMark Diagnostics (GNMK), Inovio Pharmaceuticals (INO), Utah Medical Products (UTMD), MiMedx Group (MDXG), Neuronetics (STIM), SeaSpine (SPNE), Iradimed (IRMD), Vapotherm (VAPO), Apyx Medical (APYX), Westaim (WEDXF), Cytosorbents (CTSO), Liquidia Technologies (LQDA), Nuvectra (NVTR) and T2 Biosystems (TTOO).
Who are STRATA Skin Sciences' key executives?
STRATA Skin Sciences' management team includes the folowing people:
- Dr. Dolev Rafaeli, CEO, Pres & Director (Age 55)
- Mr. Matthew C. Hill, VP & CFO (Age 50)
- Mr. Jay Sturm, Corp. Counsel & Corp. Sec. (Age 63)
- Keith Simeone, VP of Sales
- Dr. Darrell S. Rigel M.D., Ms, Faad, Chief Medical Advisor (Age 68)
Who are STRATA Skin Sciences' major shareholders?
STRATA Skin Sciences' stock is owned by many different of retail and institutional investors. Top institutional investors include Nantahala Capital Management LLC (9.24%), Broadfin Capital LLC (7.25%), Geode Capital Management LLC (0.19%), Creative Planning (0.12%), Acadian Asset Management LLC (0.11%) and Macquarie Group Ltd. (0.05%). Company insiders that own STRATA Skin Sciences stock include James L Coyne, Luann Via, Matthew C Hill and Samuel E Navarro. View Institutional Ownership Trends for STRATA Skin Sciences.
Which institutional investors are selling STRATA Skin Sciences stock?
Which institutional investors are buying STRATA Skin Sciences stock?
SSKN stock was bought by a variety of institutional investors in the last quarter, including Nantahala Capital Management LLC, Creative Planning, Acadian Asset Management LLC and Northern Trust Corp. Company insiders that have bought STRATA Skin Sciences stock in the last two years include James L Coyne, Luann Via, Matthew C Hill and Samuel E Navarro. View Insider Buying and Selling for STRATA Skin Sciences.
How do I buy shares of STRATA Skin Sciences?
Shares of SSKN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is STRATA Skin Sciences' stock price today?
One share of SSKN stock can currently be purchased for approximately $3.21.
How big of a company is STRATA Skin Sciences?
STRATA Skin Sciences has a market capitalization of $96.12 million and generates $31.45 million in revenue each year. The medical device company earns $-18,830,000.00 in net income (profit) each year or $1.97 on an earnings per share basis. STRATA Skin Sciences employs 98 workers across the globe.
What is STRATA Skin Sciences' official website?
How can I contact STRATA Skin Sciences?
STRATA Skin Sciences' mailing address is 100 LAKESIDE DRIVE SUITE 100, HORSHAM PA, 19044. The medical device company can be reached via phone at 215-619-3200 or via email at [email protected]
MarketBeat Community Rating for STRATA Skin Sciences (NASDAQ SSKN)
MarketBeat's community ratings are surveys of what our community members think about STRATA Skin Sciences and other stocks. Vote "Outperform" if you believe SSKN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SSKN will underperform the S&P 500 over the long term. You may vote once every thirty days.
